American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2026
  • »
  • April

Study finds pharmacist-led education may help patients stop benzodiazepine use

Y. Y. Jacobsen | Apr 2, 2026
Jeffrey J. Mesaros, President

A new study published in BMJ reports that pharmacist-led educational efforts may help people stop using benzodiazepines. The research analyzed data from over 39,000 patients but notes limitations regarding age range and mental health conditions. Read More »

Analysis: Three PBMs account for 80% of U.S. market share

W. K. Reid | Apr 2, 2026
Adam Fein, President of the Drug Channels Institute

In 2025, three major pharmacy benefit managers controlled about 80% of US prescription claims according to an analysis by the Drug Channels Institute. Read More »

National Community Pharmacists Association opens media studio at Alexandria headquarters

Y. Y. Jacobsen | Apr 2, 2026
B. Douglas Hoey CEO

The National Community Pharmacists Association has opened its first-ever media studio at its Alexandria headquarters. The facility aims to expand multimedia offerings like podcasts and videos for association members. Read More »

Researchers report decline in overdose deaths in early 2025

J. S. Schmidt | Apr 8, 2026
Jeffrey J. Mesaros, President

Overdose deaths dropped by about a quarter between early 2024 and early 2025 in the United States. Researchers link this trend to reduced drug initiation rates and expanded prevention programs. Read More »

ISMP urges review of ingredients in medications for patients with alpha-gal syndrome

A. L. Lopez | Apr 9, 2026
Rita K. Jew President at the Institute for Safe Medication Practices (ISMP)

The Institute for Safe Medication Practices calls attention to risks faced by patients with alpha-gal syndrome due to hidden animal-derived ingredients in food trays and medications. The group urges hospitals to improve allergy tracking systems and increase staff awareness. Read More »

FDA announces new iPLEDGE REMS modifications to begin in August 2026

A. L. Lopez | Apr 9, 2026
Jeffrey J. Mesaros, President

The Food and Drug Administration has announced changes to the iPLEDGE REMS program set for August 2026. These updates aim to reduce administrative burdens while ensuring safe use of isotretinoin. Key changes include flexibility in pregnancy testing and updated pharmacy requirements. Read More »

FDA to restrict GLP-1 APIs for non-approved compounded products

A. L. Lopez | Apr 9, 2026
Martin A Makary Commissioner at U.S. Food and Drug Administration

The Food and Drug Administration will limit GLP-1 active pharmaceutical ingredients for non-approved compounded drugs. Companies falsely advertising such products have already received warnings, and further enforcement is expected. Read More »

CMS allocates funding to all states for Rural Health Transformation Program

A. L. Lopez | Apr 9, 2026
Dr. Mehmet Oz, Administrator at Centers for Medicare & Medicaid Services

The Centers for Medicare & Medicaid Services has allocated new funding to all 50 states as part of its Rural Health Transformation Program. The initiative targets improvements in preventive and primary care services as well as digital tools for practitioners in rural communities. Read More »

FIP releases toolkit to support pharmacy-based vaccination strategies

J. S. Schmidt | Apr 9, 2026
Catherine Duggan Chief Executive Officer (CEO) at International Pharmaceutical Federation (FIP)

The International Pharmaceutical Federation has released a new toolkit offering guidance on pharmacy-based vaccination programs. The resource includes best practices on training, storage, and policies for safe vaccine delivery. Read More »

CDC recommends individual-based decision-making for hepatitis B vaccines in children

A. L. Lopez | Apr 9, 2026
Kirk Milhoan,Chair at Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices

The CDC's advisory committee now recommends an individual-based approach for hepatitis B vaccines in children. Parents are advised to consult healthcare professionals about vaccination decisions and possible antibody testing. Read More »

Michigan Liquor Control Commission promotes responsible drinking for Alcohol Awareness Month

Y. Y. Jacobsen | Apr 9, 2026
Kristin Beltzer MLCC Chair

The Michigan Liquor Control Commission urges moderation during April's Alcohol Awareness Month. Officials stress responsible choices due to health risks linked with excessive drinking. Read More »

National Community Pharmacists Association announces schedule of online and in-person events for April

A. L. Lopez | Apr 9, 2026
Kristen Riddle, PharmD | President

The National Community Pharmacists Association has released its schedule of educational webinars and workshops for pharmacists this April. Topics include Medicare updates, men’s health trends, diabetes education accreditation courses, mental health training sessions, disaster response strategies for pharmacy teams—and more. Read More »

NAHPC CEO Gremminger on 340B: 'It allows eligible hospitals to buy drugs at a deep discount and sell them at significant mark-ups'

S. D. Rosales | Apr 9, 2026
Shawn Gremminger, President & CEO at the National Alliance Of Healthcare Purchaser Coalitions

Shawn Gremminger of the National Alliance Of Healthcare Purchaser Coalitions called for reforms to New York's participation in the federal 340B Drug Pricing Program due to concerns over cost increases and lack of accountability. Read More »

PhRMA urges Congress to examine oversight and impact of 340B program

E. A. Stiles | Apr 10, 2026
Molly Jenkins, Senior Director of Public Affairs at PhRMA

PhRMA has called for increased congressional scrutiny of the federal 340B drug pricing program due to concerns about rapid expansion and insufficient oversight. Read More »

LARA reports progress on cutting regulatory barriers in Michigan licensing

J. S. Schmidt | Apr 17, 2026
Marlon I. Brown, DPA Director

The Michigan Department of Licensing and Regulatory Affairs released a new report showing major steps taken toward streamlining licensing processes. The update includes simplified exams, new career maps for skilled trades entry, expanded distance learning options for continuing education, and ongoing legislative reforms. Read More »

Cannabis Regulatory Agency announces disciplinary actions against licensees in March

Y. Y. Jacobsen | Apr 17, 2026
Marlon I. Brown, DPA Director

The Michigan Cannabis Regulatory Agency released its March disciplinary action report listing enforcement measures against numerous cannabis businesses statewide. Violations ranged from tracking system failures to improper sales practices. Full details are available through the agency's online database. Read More »

DEA finalizes rule on emergency medical services handling of controlled substances

J. S. Schmidt | Apr 18, 2026
Terry Cole, Drug Enforcement Administration Administrator

The Drug Enforcement Administration has issued a final rule clarifying how emergency medical services agencies must handle controlled substances. The regulation aligns existing DEA policies with federal law passed in 2017. Agencies must now comply with new standards covering registration, security, storage, and record keeping. Read More »

Dr. Lorna Breen Health Care Provider Protection Act reauthorized through September 2030

Y. Y. Jacobsen | Apr 18, 2026
Jeffrey J. Mesaros, President

A law supporting mental health programs for healthcare workers has been extended through September 2030. The Dr. Lorna Breen Health Care Provider Protection Reauthorization Act aims to help reduce burnout and suicide among medical professionals. Read More »

Consumer Action for a Strong Economy urges Minnesota Senate to reject 340B expansion

J. S. Schmidt | Apr 23, 2026
Gerard Daniel Scimeca, Chairman & General Counsel, CASE

Consumer Action for a Strong Economy urged Minnesota lawmakers not to expand the state's participation in the federal 340B drug pricing program. Read More »

Fmr. Gov. Jindal on PBM reforms: 'PBM reforms have shown that transparency and accountability can gain traction across party lines'

J. A. Adkins | Apr 24, 2026
Bobby Jindal, Former Governor of Louisiana

Former Governor Bobby Jindal said recent pharmacy benefit manager (PBM) reforms are an important first step toward greater transparency in drug pricing. Read More »

  • «
  • 1 (current)
  • 2
  • »
Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Marlon I. Brown, DPA Director

Cannabis Regulatory Agency releases April disciplinary actions against licensees across Michigan

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up